sesamin has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, L; Li, G; Li, Y; Lin, S; Lo, JHT; Lu, X; Tortorella, MD; Wang, H; Wang, Y; Yang, Z; Zhang, X | 1 |
| Kongtawelert, P; Phitak, T; Pothacharoen, P; Wanachewin, O | 1 |
2 other study(ies) available for sesamin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
DANCR Mediates the Rescuing Effects of Sesamin on Postmenopausal Osteoporosis Treatment via Orchestrating Osteogenesis and Osteoclastogenesis.
Topics: Animals; beta Catenin; Bone Resorption; Cell Differentiation; Dioxoles; Female; HEK293 Cells; Humans; Lignans; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal; RANK Ligand; RAW 264.7 Cells; RNA, Long Noncoding; Wnt Signaling Pathway | 2021 |
Inhibitory effects of sesamin on human osteoclastogenesis.
Topics: Bone Marrow Cells; Bone Resorption; Cell Culture Techniques; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dioxoles; Gene Expression; Healthy Volunteers; Humans; Lignans; Macrophage Colony-Stimulating Factor; Osteoclasts; Osteogenesis; RANK Ligand | 2017 |